FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2063676137> ?p ?o ?g. }

• W2063676137 endingPage "1050" @default.
• W2063676137 startingPage "1045" @default.
• W2063676137 abstract "Abstract Bartonella henselae is the causative agent of cat scratch disease in humans, which is recognized as an emerging zoonotic disease. Ctenocephalides felis is the main vector, and transmission of B. henselae infection between cats and humans occurs mainly through infected flea feces. Control of feline infestation with this arthropod vector therefore provides an important strategy for the prevention of infection of both humans and cats. In the present study, a new challenge model is used to evaluate the efficacy of selamectin (Stronghold ® spot on) in the prevention of B. henselae transmission by C. felis . In this new challenge model, domestic cats were infected by direct application of B. henselae -positive fleas. The fleas used for infestation were infected by feeding on blood that contained in vitro-cultured B. henselae . The direct application of the fleas to the animals and the use of different B. henselae strains ensured a high and consistent challenge. Two groups of six cats were randomly allocated on pre-treatment flea counts to either control (untreated cats) or the selamectin-treated group with one pipette per cat according to the label instruction. Stronghold (selamectin 6 % spot on solution) was administered on days 0 and 32. On days 3, 10, 19, 25, and 31, each cat was infested by direct application of 20 fleas that fed on blood inoculated with B. henselae . Polymerase chain reaction (PCR) on pooled fleas confirmed that the fleas were infected. Blood samples were collected from each cat on days −3 (prior to flea infestation and treatment), 9, 17, 24, 30, 37, and 44 and assayed for B. henselae antibodies using an indirect immunofluorescence (IFA), for the presence of bacteria by bacterial culture and for B. henselae DNA presence by PCR. Cats were also assessed on a daily basis for general health. There were no abnormal health observations during the study and none of the animals required concomitant treatment. None of the cats displayed any clinical signs of bartonellosis during the study. In the untreated group, all cats became bacteremic within 17 to 44 days. None of the selamectin-treated cats became positive during the study. It was concluded that Stronghold ® spot on administered to cats was efficacious in the prevention of the transmission of B. henselae by fleas to cats in a high-challenge model." @default.
• W2063676137 created "2016-06-24" @default.
• W2063676137 creator A5010421099 @default.
• W2063676137 creator A5011206497 @default.
• W2063676137 creator A5016314514 @default.
• W2063676137 creator A5030845037 @default.
• W2063676137 creator A5051621481 @default.
• W2063676137 creator A5063166915 @default.
• W2063676137 creator A5065201000 @default.
• W2063676137 creator A5082448140 @default.
• W2063676137 creator A5084748266 @default.
• W2063676137 creator A5090857176 @default.
• W2063676137 date "2015-01-14" @default.
• W2063676137 modified "2023-09-29" @default.
• W2063676137 title "The efficacy of a selamectin (Stronghold®) spot on treatment in the prevention of Bartonella henselae transmission by Ctenocephalides felis in cats, using a new high-challenge model" @default.
• W2063676137 cites W1548859204 @default.
• W2063676137 cites W1604612617 @default.
• W2063676137 cites W1686939297 @default.
• W2063676137 cites W1837139523 @default.
• W2063676137 cites W1978980996 @default.
• W2063676137 cites W1985031846 @default.
• W2063676137 cites W2005276251 @default.
• W2063676137 cites W2005594808 @default.
• W2063676137 cites W204264571 @default.
• W2063676137 cites W2050035060 @default.
• W2063676137 cites W2052026518 @default.
• W2063676137 cites W2061782159 @default.
• W2063676137 cites W2066030746 @default.
• W2063676137 cites W2066854367 @default.
• W2063676137 cites W2078281389 @default.
• W2063676137 cites W2095971168 @default.
• W2063676137 cites W2112592442 @default.
• W2063676137 cites W2118874922 @default.
• W2063676137 cites W2119828927 @default.
• W2063676137 cites W2124211357 @default.
• W2063676137 cites W2124816337 @default.
• W2063676137 cites W2127651807 @default.
• W2063676137 cites W2132284508 @default.
• W2063676137 cites W2132483067 @default.
• W2063676137 cites W2137711930 @default.
• W2063676137 cites W2149813943 @default.
• W2063676137 cites W2160088564 @default.
• W2063676137 cites W2160225759 @default.
• W2063676137 cites W2174305860 @default.
• W2063676137 cites W2409724360 @default.
• W2063676137 cites W2410894356 @default.
• W2063676137 cites W4301934848 @default.
• W2063676137 cites W6270911 @default.
• W2063676137 doi "https://doi.org/10.1007/s00436-014-4271-4" @default.
• W2063676137 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4336412" @default.
• W2063676137 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25582566" @default.
• W2063676137 hasPublicationYear "2015" @default.
• W2063676137 type Work @default.
• W2063676137 sameAs 2063676137 @default.
• W2063676137 citedByCount "5" @default.
• W2063676137 countsByYear W20636761372015 @default.
• W2063676137 countsByYear W20636761372019 @default.
• W2063676137 countsByYear W20636761372021 @default.
• W2063676137 countsByYear W20636761372022 @default.
• W2063676137 crossrefType "journal-article" @default.
• W2063676137 hasAuthorship W2063676137A5010421099 @default.
• W2063676137 hasAuthorship W2063676137A5011206497 @default.
• W2063676137 hasAuthorship W2063676137A5016314514 @default.
• W2063676137 hasAuthorship W2063676137A5030845037 @default.
• W2063676137 hasAuthorship W2063676137A5051621481 @default.
• W2063676137 hasAuthorship W2063676137A5063166915 @default.
• W2063676137 hasAuthorship W2063676137A5065201000 @default.
• W2063676137 hasAuthorship W2063676137A5082448140 @default.
• W2063676137 hasAuthorship W2063676137A5084748266 @default.
• W2063676137 hasAuthorship W2063676137A5090857176 @default.
• W2063676137 hasBestOaLocation W20636761371 @default.
• W2063676137 hasConcept C119599485 @default.
• W2063676137 hasConcept C126322002 @default.
• W2063676137 hasConcept C127413603 @default.
• W2063676137 hasConcept C142724271 @default.
• W2063676137 hasConcept C159047783 @default.
• W2063676137 hasConcept C159654299 @default.
• W2063676137 hasConcept C203014093 @default.
• W2063676137 hasConcept C2776347271 @default.
• W2063676137 hasConcept C2776451879 @default.
• W2063676137 hasConcept C2777534959 @default.
• W2063676137 hasConcept C2777535154 @default.
• W2063676137 hasConcept C2777786777 @default.
• W2063676137 hasConcept C2778256364 @default.
• W2063676137 hasConcept C2779134260 @default.
• W2063676137 hasConcept C2779254346 @default.
• W2063676137 hasConcept C2779904517 @default.
• W2063676137 hasConcept C42972112 @default.
• W2063676137 hasConcept C45189115 @default.
• W2063676137 hasConcept C59822182 @default.
• W2063676137 hasConcept C71924100 @default.
• W2063676137 hasConcept C761482 @default.
• W2063676137 hasConcept C86803240 @default.
• W2063676137 hasConcept C89423630 @default.
• W2063676137 hasConcept C90856448 @default.
• W2063676137 hasConceptScore W2063676137C119599485 @default.
• W2063676137 hasConceptScore W2063676137C126322002 @default.
• W2063676137 hasConceptScore W2063676137C127413603 @default.

• next